shortagewatch

Home / Genito-urinary system and sex hormones / Tamsulosin and Solifenacin

ATC G04CA53 · Urologicals

Tamsulosin and Solifenacin shortage

As of 31 Oct 2026, Tamsulosin and Solifenacin has a reported shortage in 4 of the 5 countries we track (Italy, Spain, Austria, Belgium), covering 13 products.

Countries4/5
Products13packs or presentations
Short since23 Feb 20268 months ago
Earliest return16 Nov 2026company estimate
No return date1products
Main reasonOther

Timeline

ItalySpainAustriaBelgium
2027SOLIFENACINA E TAMSULOSIN MYLANSOLIFENACINA E TAMSULOSIN MYLANSOLIFENACINA/TAMSULOSINA STADAFARMA 6 MG/0,4SOLIFENACINA/TAMSULOSINA STADAFARMA 6 MG/0,4 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG, 30 comprimidosSOLIFENACINA/TAMSULOSINA PENSA 6 MG/0,4 MG CSOLIFENACINA/TAMSULOSINA PENSA 6 MG/0,4 MG COMPRIMIDOS DE LIBERACIÓN MODIFICADA EFG, 30 comprimidosDAITAL 6 MG/0,4 MG COMPRIMIDOS DE LIBERACIÓNDAITAL 6 MG/0,4 MG COMPRIMIDOS DE LIBERACIÓN MODIFICADA EFG, 30 comprimidosSolicomp 6 mg/0,4 mg Tabletten mit verändertSolicomp 6 mg/0,4 mg Tabletten mit veränderter Wirkstofffreisetzung, 30 StückSolifenacine/Tamsulosine Viatris 6 mg - 0.4 Solifenacine/Tamsulosine Viatris 6 mg - 0.4 mg tabl. modif.-rel. 90 (90 x 1) UDSolifenacine/Tamsulosine AB 6 mg - 0.4 mg taSolifenacine/Tamsulosine AB 6 mg - 0.4 mg tabl. modif.-rel. 90Solifenacine/Tamsulosine Viatris 6 mg - 0.4 Solifenacine/Tamsulosine Viatris 6 mg - 0.4 mg tabl. modif.-rel. 200Solifenacine/Tamsulosine Viatris 6 mg - 0.4 Solifenacine/Tamsulosine Viatris 6 mg - 0.4 mg tabl. modif.-rel. 30 (30 x 1) UDSolifenacine/Tamsulosine EG 6 mg - 0.4 mg taSolifenacine/Tamsulosine EG 6 mg - 0.4 mg tabl. modif.-rel. 30 (30 x 1) UDSolifenacine/Tamsulosine EG 6 mg - 0.4 mg taSolifenacine/Tamsulosine EG 6 mg - 0.4 mg tabl. modif.-rel. 90 (90 x 1) UDSolifenacine/Tamsulosine AB 6 mg - 0.4 mg taSolifenacine/Tamsulosine AB 6 mg - 0.4 mg tabl. modif.-rel. 30Solifenacine/Tamsulosine Teva 6 mg - 0.4 mg Solifenacine/Tamsulosine Teva 6 mg - 0.4 mg tabl. modif.-rel. 90 (90 x 1) UDtoday

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Affected products

CountryProductHolderSinceExpected backReason
ITSOLIFENACINA E TAMSULOSIN MYLANMYLAN S.P.A.1 Oct 2026not givenManufacturing problem
Problemi produttivi
ESSOLIFENACINA/TAMSULOSINA STADAFARMA 6 MG/0,4 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG, 30 comprimidosLaboratorio Stada S.L.14 Jun 202629 Nov 2026Not stated
ESSOLIFENACINA/TAMSULOSINA PENSA 6 MG/0,4 MG COMPRIMIDOS DE LIBERACIÓN MODIFICADA EFG, 30 comprimidosTowa Pharmaceutical S.A.29 Sep 202629 Nov 2026Not stated
ESDAITAL 6 MG/0,4 MG COMPRIMIDOS DE LIBERACIÓN MODIFICADA EFG, 30 comprimidosLaboratorios Alter S.A.14 Oct 202629 Nov 2026Not stated
ATSolicomp 6 mg/0,4 mg Tabletten mit veränderter Wirkstofffreisetzung, 30 StückAba-Pharm GmbH29 Sep 20261 Feb 2027Manufacturing problem
Verzögerung bei der Herstellung
BESolifenacine/Tamsulosine Viatris 6 mg - 0.4 mg tabl. modif.-rel. 90 (90 x 1) UDViatris GX23 Feb 202616 Dec 2026Other
Other reason
BESolifenacine/Tamsulosine AB 6 mg - 0.4 mg tabl. modif.-rel. 90Aurobindo17 Apr 202615 Dec 2026Other
Other reason
BESolifenacine/Tamsulosine Viatris 6 mg - 0.4 mg tabl. modif.-rel. 200Viatris GX7 Jul 202616 Dec 2026Other
Other reason
BESolifenacine/Tamsulosine Viatris 6 mg - 0.4 mg tabl. modif.-rel. 30 (30 x 1) UDViatris GX5 Aug 202618 Nov 2026Other
Other reason
BESolifenacine/Tamsulosine EG 6 mg - 0.4 mg tabl. modif.-rel. 30 (30 x 1) UDEG10 Aug 202616 Nov 2026Manufacturing problem
Delay in production
BESolifenacine/Tamsulosine EG 6 mg - 0.4 mg tabl. modif.-rel. 90 (90 x 1) UDEG10 Aug 202616 Nov 2026Manufacturing problem
Delay in production
BESolifenacine/Tamsulosine AB 6 mg - 0.4 mg tabl. modif.-rel. 30Aurobindo26 Aug 202615 Dec 2026Other
Other reason
BESolifenacine/Tamsulosine Teva 6 mg - 0.4 mg tabl. modif.-rel. 90 (90 x 1) UDTeva14 Sep 202623 Nov 2026Increased demand

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.

Related medicines also in short supply